Accordingly, the MYC-target gene PLK1 was one of the top upregulated genes in RB1ko, which fits the anti-proliferative effect of PLK1-inhibition in retinoblastoma cell lines [9]. The gene discussed is MYC; the disease is retinoblastoma.